April 9 is 'Uterus Day' - AstraZeneca Holds Gynecological Cancer Awareness Seminar 'Learn and Prepare: Women's Cancer and Career'
On April 9, AstraZeneca co-hosted a seminar with FamiOne for female employees of over 50 companies, raising awareness on gynecological cancers and career balance.
📋 Article Processing Timeline
- 📰 Published: April 10, 2026 at 02:30
- 🔍 Collected: April 10, 2026 at 09:01 (6h 31m after Published)
- 🤖 AI Analyzed: April 20, 2026 at 07:33 (238h 31m after Collected)
AstraZeneca K.K. (Headquarters: Kita-ku, Osaka City, Representative Director and President: Andrew Burnett, hereafter AstraZeneca) held a gynecological cancer awareness seminar titled 'Learn and Prepare: Women's Cancer and Career' on Thursday, April 9, 'Uterus Day.' This seminar was held as a co-hosted event with FamiOne, Inc., which mainly develops health support services according to the changes in women's life stages. Targeting female employees working in over 50 companies, the event aimed to promote early detection and gynecological checkups by enhancing knowledge about gynecological cancers and understanding the significance of screenings.
'Gynecological cancer' is a collective term for cancers arising from female-specific organs such as ovaries and the uterus. In recent years, the number of women diagnosed with ovarian cancer and uterine cancer (endometrial cancer, cervical cancer) has been increasing, with the peak onset age being in the 50s-60s for ovarian and endometrial cancers, and in the 30s-50s for cervical cancer. While screenings are recommended as a public preventive measure for cervical cancer for those aged 20 and above, there are no publicly implemented screenings with established effectiveness for ovarian and endometrial cancers, so it is recommended to notice symptoms early and consult a gynecologist.
The seminar kicked off with a lecture on 'Aiming to Balance Cancer and Career' by Ms. Yuri Yoshida (Co-Representative Director, Cancer and Work Support Group). Based on her own experience with ovarian cancer treatment, she detailed the key points of communication with the workplace and utilizing support systems to balance treatment and work. Practically, she emphasized that managing screening dates as regular appointments, confirming the details of various systems stipulated in employment regulations, and sharing information with family and colleagues are the keys to 'cancer preparedness.' Regarding support systems, she sent a message that the attitude of 'utilizing them before it's too late' is important.
Next, Dr. Mayu Onsegawa (Gynecologic Oncologist, Deputy Director of Gynecology and Chief of Comprehensive Oncology, The Cancer Institute Hospital of JFCR) gave a lecture on 'Basic Knowledge of Gynecological Cancers.' While prevention and early detection are becoming possible for cervical cancer through vaccines and screenings recommended by the Ministry of Health, Labour and Welfare, there are no highly effective established screenings for ovarian or endometrial cancers. Dr. Onsegawa advised, 'We recommend adding a transvaginal ultrasound to your health checkup to know the condition of your ovaries and uterus. Furthermore, please consult a clinic if you notice irregular bleeding, a typical initial symptom of endometrial cancer.'
'Gynecological cancer' is a collective term for cancers arising from female-specific organs such as ovaries and the uterus. In recent years, the number of women diagnosed with ovarian cancer and uterine cancer (endometrial cancer, cervical cancer) has been increasing, with the peak onset age being in the 50s-60s for ovarian and endometrial cancers, and in the 30s-50s for cervical cancer. While screenings are recommended as a public preventive measure for cervical cancer for those aged 20 and above, there are no publicly implemented screenings with established effectiveness for ovarian and endometrial cancers, so it is recommended to notice symptoms early and consult a gynecologist.
The seminar kicked off with a lecture on 'Aiming to Balance Cancer and Career' by Ms. Yuri Yoshida (Co-Representative Director, Cancer and Work Support Group). Based on her own experience with ovarian cancer treatment, she detailed the key points of communication with the workplace and utilizing support systems to balance treatment and work. Practically, she emphasized that managing screening dates as regular appointments, confirming the details of various systems stipulated in employment regulations, and sharing information with family and colleagues are the keys to 'cancer preparedness.' Regarding support systems, she sent a message that the attitude of 'utilizing them before it's too late' is important.
Next, Dr. Mayu Onsegawa (Gynecologic Oncologist, Deputy Director of Gynecology and Chief of Comprehensive Oncology, The Cancer Institute Hospital of JFCR) gave a lecture on 'Basic Knowledge of Gynecological Cancers.' While prevention and early detection are becoming possible for cervical cancer through vaccines and screenings recommended by the Ministry of Health, Labour and Welfare, there are no highly effective established screenings for ovarian or endometrial cancers. Dr. Onsegawa advised, 'We recommend adding a transvaginal ultrasound to your health checkup to know the condition of your ovaries and uterus. Furthermore, please consult a clinic if you notice irregular bleeding, a typical initial symptom of endometrial cancer.'